drugset / Trial / NCT01951898
Effects of Montelukast on Airway Regulatory T Cells in Asthma
RandomizedCrossoverDouble-blindTreatment
Summary
Montelukast is one of anti-inflammatory agents and a good controller for the patients with asthma. The hypothesis of the study is that the Montelukast will have airway anti-inflammatory effects and up-regulated regulatory T cells functions in asthma.
Timeline
- Start
- 2012-06
- Primary completion
- 2013-12
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Montelukast | Other / unclassified | 10 mg | — |